Molar Pregnancy
An abnormal pregnancy where a non-viable fertilized egg implants and grows rapidly into a mass of cysts, carrying a risk of cancer.
Emergency Management: Massive hemorrhage during or after evacuation or thyroid storm precipitated by anesthesia; requires aggressive fluid resuscitation, blood products, and antithyroid medications (PTU, beta-blockers).
A molar pregnancy, or hydatidiform mole, is an abnormal pregnancy characterized by the cystic swelling of chorionic villi and proliferation of the trophoblastic epithelium. It is a premalignant form of gestational trophoblastic disease (GTD) and is classified into complete and partial moles based on genetic makeup and morphology.
Detailed Overview
A complete mole usually results from the fertilization of an empty ovum by one or two sperm, yielding a 46,XX or 46,XY karyotype of entirely paternal origin, with no fetal tissue present. A partial mole typically results from two sperm fertilizing a normal ovum, yielding a triploid karyotype (69,XXX, 69,XXY, or 69,XYY) with some fetal tissue present. Because trophoblastic tissue secretes human chorionic gonadotropin (hCG), levels are markedly elevated, causing exaggerated pregnancy symptoms (hyperemesis, hyperthyroidism). Both types carry a risk of progressing to gestational trophoblastic neoplasia (GTN), including choriocarcinoma, mandating careful post-evacuation monitoring.
Epidemiology & Demographics
Incidence is roughly 1 in 1,000 pregnancies in North America and Europe, but significantly higher (up to 1 in 120) in Southeast Asia. Complete moles are more common than partial moles.
Etiological Mechanism
Arises from abnormal fertilization events leading to an imbalance of maternal and paternal chromosomes, specifically an excess of paternal genomic imprinting which drives excessive trophoblastic proliferation.
Primary Causes
["Fertilization of an empty egg by one sperm that duplicates (Complete mole, 46,XX)", "Fertilization of an empty egg by two sperm (Complete mole, 46,XY or 46,XX)", "Fertilization of a normal egg by two sperm (Partial mole, 69,XXY, 69,XXX, or 69,XYY)"]
The abnormal genomic constitution leads to dysregulated placental development. The chorionic villi become edematous and vesicular (forming grape-like cysts), and the syncytiotrophoblast and cytotrophoblast layers proliferate abnormally. The excessive trophoblastic mass secretes massive amounts of hCG. Extremely high hCG mimics TSH (causing hyperthyroidism) and LH/FSH (causing bilateral theca lutein ovarian cysts).
Diagnostic Criteria & Guidelines
Diagnosis is based on characteristic ultrasound findings (snowstorm appearance) and markedly elevated quantitative beta-hCG, confirmed definitively by histological examination of the evacuated products of conception.
Suction curettage (suction dilation and curettage, D&C) under ultrasound guidance to completely evacuate the uterus. Administer IV Oxytocin post-evacuation to control bleeding. Send tissue for cytogenetics and pathology.
Second-Line & Adjunctive Therapy
Hysterectomy with preservation of adnexa is an option for patients who have completed childbearing, which reduces the risk of post-molar GTN from 20% to ~3%, but post-op hCG monitoring is still required.
Surgical & Procedural Management
Suction D&C is the primary surgical management. Sharp curettage is generally avoided due to the high risk of uterine perforation.
Patient Counseling & Advice
Inform the patient that pregnancy must be strictly avoided during the surveillance period, as a new pregnancy will cause hCG to rise, masking a potential malignant recurrence of the mole. Acknowledge the emotional impact of the pregnancy loss.
Follow-Up & Monitoring Schedule
Weekly quantitative serum hCG until levels are undetectable (zero) for 3 consecutive weeks, then monthly for 6 months. Reliable contraception must be used for the duration of this period.
Preventive Strategies
There is no way to prevent a molar pregnancy. Early baseline ultrasounds in future pregnancies (at 8-10 weeks) are recommended to confirm normal development.
Survival is nearly 100% with appropriate evacuation and monitoring. Even if GTN (choriocarcinoma or invasive mole) develops, it is highly sensitive to chemotherapy (e.g., Methotrexate) with cure rates >95%.